comparemela.com

Page 2 - Steatosis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novel stem cell treatment could revolutionize liver disease management

Mortality related to end stage liver disease is ranked as the 12th most common cause of death in the U.S. Liver transplantation remains the only treatment for end stage liver disease, but there is a critical shortage of organ donors, necessitating a dire need for new forms of treatment.

New insights into the cellular programs that promote resolution of inflammation during aging

Sleep time may mediate the relationship between body fat and hepatic steatosis in young people

1. In this cross-sectional study, the association between sleep time and hepatic steatosis index (HSI) was dependent on body mass index (BMI). 2. However, analyses showed that sleep time may explain 39% of the relationship between body fat distribution and HSI. Evidence Rating Level: 3 (Average) It is well known that sleep is a factor

Wellness Check: Sleep | 2 Minute Medicine

Several exercise modalities improve sleep quality in patients with sleep disorders 1. In this systematic review and network meta-analysis, mind-body exercise, moderate aerobic exercise combined with light strength exercise, and moderate aerobic exercise alone were more effective than passive controls in improving sleep quality in those with sleep disorders. 2. However, the most effective treatment

Study identifies key markers for early detection of fatty liver disease in obese and non-obese individuals

In a study published in 'Scientific Reports', researchers found that insulin resistance markers TyG-BMI and HOMA-IR effectively predict non-alcoholic fatty liver disease (NAFLD) risks in non-obese and obese individuals without diabetes, respectively. These findings suggest new, non-invasive methods for early NAFLD detection, particularly in atypical non-obese cases.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.